Mead Johnson Nutrition CO

Material Contracts Filter

EX-10.18
from S-1/A 26 pages Separately With the Securities and Exchange Commission. Supply Agreement
12/34/56
EX-10.17
from S-1/A 16 pages Bristol-Myers Squibb Company 1997 Stock Incentive Plan
12/34/56
EX-10.16
from S-1/A 7 pages Bristol-Myers Squibb Company Teamshare Stock Option Plan
12/34/56
EX-10.15
from S-1/A 22 pages Bristol-Myers Squibb Company 2002 Stock Incentive Plan
12/34/56
EX-10.14
from S-1/A 26 pages Bristol-Myers Squibb Company 2007 Stock Award and Incentive Plan
12/34/56
EX-10.13
from S-1/A 17 pages Mead Johnson Nutrition Company 2009 Senior Executive Performance Incentive Plan
12/34/56
EX-10.12
from S-1/A 35 pages Mead Johnson Nutrition Company 2009 Stock Award and Incentive Plan
12/34/56
EX-10.11
from S-1/A 6 pages September 2, 2008 Mr. Peter G. Leemputte 1656 Kathryn Lane Lake Forest, Il 60045 Dear Pete,
12/34/56
EX-10.10
from S-1/A 7 pages I Am Pleased to Confirm Your International Assignment to Bangkok, Thailand, on Behalf of Bristol-Myers Squibb Company (“Company”). This Letter Outlines the Terms of Our Agreement Including Your Compensation and Other Financial Arrangements. Many of These Terms Are Contained in the Company’s Global Expatriate Assignment Policy (“Policy”), to Which You Should Refer for Additional Information Regarding Each of the Topics Herein. the Company Reserves the Right to Modify the Provisions of the Global Expatriate Assignment Policy at Its Discretion. You Will Be Notified of Any Policy Changes as They Are Implemented. Position
12/34/56
EX-10.9
from S-1/A 7 pages You Will Assume the Position of President, Mead Johnson Nutritionals (Level E09) and Will Report Directly to Lamberto Andreotti, Senior Vice President and President International. the Assignment Will Begin on January 1, 2004 and Is Located at the Evansville, Indiana Facility. You Will Need to Obtain an L-1 Visa Prior to Beginning Employment in the U.S. the Company Will Engage Assistance With Obtaining the Necessary Visa for Employment in the U.S. Compensation
12/34/56
EX-10.8
from S-1/A 15 pages Bristol-Myers Squibb Company Change in Control Separation Benefits Plan and Summary Plan Description
12/34/56
EX-10.3
from S-1/A 10 pages Personal & Confidential Agreement
12/34/56
EX-10.2
from S-1/A 9 pages Personal & Confidential Agreement
12/34/56
EX-10.1
from S-1/A 12 pages Personal & Confidential Agreement
12/34/56